Daily Review 21/09/2015

18 comments on “Daily Review 21/09/2015”

Comment numbers have changed to permanent references. Older quoted numbers may no longer identify the same comment.

    1. 1.1

      Quick play some music over the top of Dita before she tells everyone what the hell is going on in media and so the host doesn’t feel too awkward.

      1. 1.1.1

        Yep I heard her talk and I thought it was the most important thing said on Nat Rad today and she was cut off and trivialised …

  1. 4

    lols. Whoever digs up these Daily Review sketches/pictures deserves a medal.

    [Thanks Anne.

    One of my daily jobs is to scour Facebook and twitter and find the ultimate graphic. I had a couple of other potential graphics but they were really pushing the boundaries … MS]

    1. 5.1

      Yes there are still a couple of “scientists” who for what ever reason – mainly funding from the Oil industry – have closed their minds to reality. And reported in NZ Farmer! Well knock me down with a feather!

      1. 5.1.1

        He is a fertilizer seller and rather ironically attacks anything non mainstream because if it isn’t backed by solid science , put this up in the hope that someone cleverer than me might rebutt his claims in a letter to nz farmer.

    2. 5.2

      I didnt read the article, the title was enough for me.

      Deniers talk about vested intrests, but there is a lot of money to be made out of trashing the environment. A lot more than protecting it.

  2. 7

    This is what the TPPA will do to the price of drugs in NZ:

    A drug treating a common parasite that attacks people with weakened immune systems increased in cost 5,000% to $750 per pill.

    At a time of heightened attention to the rising cost of prescription drugs, doctors who treat patients with AIDS and cancer are denouncing the new cost to treat a condition that can be life-threatening.

    Turing Pharmaceuticals of New York raised the price of Daraprim from $13.50 per pill to $750 per pill last month, shortly after purchasing the rights to the drug from Impax Laboratories. Turing has exclusive rights to market Daraprim (pyrimethamine), on the market since 1953.

    Thing is, a drug that old shouldn’t even have any such exclusive rights left.

        1. 7.1.1.1

          Even if that is the case which is highly doubtful as to how it might affect pharmaceuticals in NZ, the product that you have highlighted is out of patent.

          The price has more to do with a ‘dysfunctional market’ in the USA if you like, as no one else has registered the drug in the USA. In NZ the medicine used here isn’t even registered by Medsafe as it’s so seldom used and it’s supplied under what’s known as Section 29 for unregistered medicines at around $37 per 50tabs.

          I’ve made comment here…

          http://thestandard.org.nz/open-mike-22092015/#comment-1073109

Comments are closed.